Essayer OR - Gratuit
Saudi Arabia pledges $500M to protect children from polio
BioSpectrum Asia
|June 2024
At the first-ever World Economic Forum (WEF) Special Meeting hosted in Riyadh recently, the Kingdom of Saudi Arabia has pledged $500 million over the next five years to support the work of the Global Polio Eradication Initiative (GPEI).
-
Cette histoire est tirée de l'édition June 2024 de BioSpectrum Asia.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE BioSpectrum Asia
BioSpectrum Asia
Biotechnology to Drive Next Industrial Revolution: Dr Jitendra Singh
\"Biotechnology will play a defining role in shaping the next industrial revolution and will be a key driver of global and Indian economic growth\", said Dr Jitendra Singh, the Union Minister of State (Independent Charge) for Science and Technology.
1 mins
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Cartherics names Dr lan Nisbet as CEO
Australia-based Cartherics, a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women's diseases, with lead programmes in ovarian cancer and endometriosis, has announced the appointment of Dr Ian Nisbet as Chief Executive Officer, as part of a planned leadership transition.
1 min
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Neurophet ropes in Josh Cohen as Head of Americas Business
South Korea-based Neurophet, an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, has appointed Josh Cohen, a veteran executive from leading global medical device companies, as new Head of Americas Business.
1 min
BioSpectrum Asia Jan 2026
BioSpectrum Asia
India's Final Mile to TB Elimination
As the target year 2025 draws to a close, the Government of India has intensified and consolidated nationwide efforts to eliminate tuberculosis (TB) through the TB-Mukt Bharat Abhiyaan, implemented under the National Tuberculosis Elimination Programme (NTEP). India's decision to advance the TB elimination timeline ahead of global targets has driven sustained reforms across detection, treatment, prevention, nutrition support, and community engagement.
2 mins
BioSpectrum Asia Jan 2026
BioSpectrum Asia
"Industry needs to evolve and invest in ADC payloads with more differentiated mechanisms of action
Antibody drug conjugates (ADCs) are becoming highly valuable in the market, with currently 15 approved ADCs targeting 16 different indications for haematological and solid tumour malignancies. With key components of ADCs, such as mAbs, linkers, payloads, and conjugation technologies, undergoing rapid advancements, a solid foundation has been laid for future research and development in this field, particularly in North America which is the largest market shareholder for ADCs. US recently wrapped up the world's largest & definitive Antibody-Drug Conjugate event, World ADC, held in November 2025, highlighting the development of novel ADCs through key market players, and a surge in patent application filing for ADCs. Dr Allan Jordan, Vice President of Oncology Drug Discovery at Sygnature Discovery, UK spoke in detail with BioSpectrum Asia about the future outlook of ADCs.
4 mins
BioSpectrum Asia Jan 2026
BioSpectrum Asia
BioSpectrum Excellence Awards Highlight Strength and Future of India's Biotechnology Sector
Former Secretary, Department of Biotechnology (DBT), Government of India, Dr Renu Swarup, underscored the importance of recognising excellence across the biotechnology ecosystem while chairing the jury at the BioSpectrum Excellence Awards.
1 min
BioSpectrum Asia Jan 2026
BioSpectrum Asia
How Precision Medicine Is Reshaping Cancer Care
Despite major advances in cancer detection and treatment, high recurrence rates and progression to advanced disease continue to challenge outcomes across Asia-making precision medicine a critical catalyst for shifting cancer care from disease management toward treat-to-cure.
2 mins
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Nona Biosciences appoints Dr Hongjiang Miao as Chief AI Officer
Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development from Idea to IND, has announced the appointment of Dr Hongjiang Miao as Chief AI Officer.
1 min
BioSpectrum Asia Jan 2026
BioSpectrum Asia
There are talent shortages in specialised modalities such as ADCs, peptides, and computational biology
As the Asia Pacific (APAC) contract development and manufacturing organisation (CDMO) sector continues to expand rapidly due to rising R&D investment, strong biotech formation, increased demand for Investigational New Drug (IND) - enabling and early Chemistry, Manufacturing, and Controls (CMC) services, and national incentives for biomanufacturing, KBI Biopharma is focused on targeted expansion into Japan, Korea, Taiwan, and Australia, for improving local engagement and enhancing access to global network. BioSpectrum Asia spoke to Katie Edgar, Chief Business Officer, KBI Biopharma to learn more about the company's growth plans in 2026, and about the growth opportunities in store for the CDMO market within the APAC region.
4 mins
BioSpectrum Asia Jan 2026
BioSpectrum Asia
MMA Spectrum Foundation Launches Initiative to Support Startups and Young Innovators
The MMA Spectrum Foundation, an initiative of the MM Activ Group, has announced its commitment to encouraging startups by providing structured support to young innovators with entrepreneurial vision.
1 min
BioSpectrum Asia Jan 2026
Listen
Translate
Change font size